Holen Sie sich die Stockscreener-App
6.80
3.27%
-0.23
Schlusskurs vom Vortag:
$7.03
Offen:
$7.02
24-Stunden-Volumen:
70,332
Relative Volume:
0.15
Marktkapitalisierung:
$10.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-5.913
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
-9.09%
1M Leistung:
+65.05%
6M Leistung:
-8.80%
1J Leistung:
-83.17%
1-Tages-Spanne:
$6.61
$7.11
1-Wochen-Bereich:
$6.61
$7.98
52-Wochen-Spanne:
$3.80
$41.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
6.80 | 11.14M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
How Acurx Pharmaceuticals Inc. stock responds to policy changesWeekly Risk Report & Real-Time Volume Trigger Notifications - Trung tâm Dự báo KTTV quốc gia
Can Acurx Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Can swing trading help recover from Acurx Pharmaceuticals Inc. lossesTrade Ideas & Low Risk Investment Opportunities - newser.com
What Fibonacci levels say about Acurx Pharmaceuticals Inc. reboundJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Multi factor analysis applied to Acurx Pharmaceuticals Inc.July 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Acurx Pharmaceuticals Inc Stock Analysis and ForecastEarnings Season Recap & Small Investment Trading Tips - earlytimes.in
Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveQuarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsChart Signals & High Win Rate Trade Alerts - newser.com
Will Acurx Pharmaceuticals Inc. stock split attract more investorsJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
How Acurx Pharmaceuticals Inc. (3ZO) stock reacts to fiscal policiesMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Why retail investors favor Acurx Pharmaceuticals Inc. stockWeekly Risk Report & High Conviction Trade Alerts - newser.com
Acurx Pharmaceuticals Inc.’s volatility index tracking explainedMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Kansas City Star
Acurx Pharmaceuticals, Inc.Common Stock (NQ: ACXP - FinancialContent
Acurx Pharmaceuticals (NASDAQ:ACXP) Raised to Hold at Wall Street Zen - Defense World
Acurx Pharmaceuticals granted Australian patent for antibiotics - Investing.com Australia
Acurx Pharmaceuticals granted Australian patent for antibiotics By Investing.com - Investing.com Nigeria
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Stock Titan
Measuring Acurx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com
Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real? - ts2.tech
What drives Acurx Pharmaceuticals Inc stock pricePrice-to-Earnings Ratio Insights & High Return Market Tips - earlytimes.in
Pharma Boom: Acurx on the Rise - StocksToTrade
ACXP’s Steady Climb: New Developments? - timothysykes.com
90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions - ts2.tech
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Corpus Christi Caller-Times
Will breakout in Acurx Pharmaceuticals Inc. lead to full recoveryPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stockInsider Buying & Weekly Stock Performance Updates - newser.com
Acurx Pharmaceuticals Inc. stock trendline breakdownChart Signals & Long-Term Investment Growth Plans - newser.com
Will Acurx Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - Tacoma News Tribune
Acurx Pharmaceuticals (NASDAQ:ACXP) Lowered to Sell Rating by Wall Street Zen - Defense World
Will Acurx Pharmaceuticals Inc. (3ZO) stock return to pre crash levels2025 Price Action Summary & Comprehensive Market Scan Insights - newser.com
Chart overlay techniques for tracking Acurx Pharmaceuticals Inc.2025 Support & Resistance & Consistent Profit Alerts - newser.com
Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Canada
Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):